Journal article
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults
Abstract
To determine if newer influenza vaccines can safely improve seroprotection rates of older adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized, controlled trial with evaluator blinding. Participants were non-frail adults ≥ 65 y old, annually TIV-immunized. Study vaccines included intradermal (IDV), MF59-adjuvanted (ADV) and subunit (TIV) formulations of equal potency and strain composition. Blood was obtained …
Authors
Scheifele DW; McNeil SA; Ward BJ; Dionne M; Cooper C; Coleman B; Loeb M; Rubinstein E; McElhaney J; Hatchette T
Journal
Human Vaccines & Immunotherapeutics, Vol. 9, No. 11, pp. 2460–2473
Publisher
Taylor & Francis
Publication Date
November 2013
DOI
10.4161/hv.25580
ISSN
2164-5515